Literature DB >> 9242179

Hemodynamic regulation of tumor necrosis factor-alpha gene and protein expression in adult feline myocardium.

S R Kapadia1, H Oral, J Lee, M Nakano, G E Taffet, D L Mann.   

Abstract

Tumor necrosis factor-alpha (TNF-alpha) mRNA and protein biosynthesis were examined in adult feline myocardium in the presence and absence of superimposed hemodynamic pressure overloading. A brief period of hemodynamic pressure overloading ex vivo resulted in de novo TNF-alpha mRNA expression within 30 minutes and de novo TNF-alpha protein production within 60 minutes; neither TNF-alpha mRNA nor protein was detected in hearts perfused at normal perfusion pressures. Moreover, TNF-alpha mRNA and protein biosynthesis were observed in myocyte and nonmyocyte cell types in the pressure-overloaded hearts. To determine whether a simple passive stretch of the myocardium was a sufficient stimulus for TNF-alpha biosynthesis, we examined TNF-alpha mRNA expression in stretched and unstretched papillary muscles. This study showed that myocardial stretch was a sufficient stimulus for the induction of TNF-alpha mRNA biosynthesis. The functional significance of the intramyocardial production of TNF-alpha was determined by examining cell motion in isolated contracting cardiac myocytes treated with superfusates from pressure-overloaded and control hearts. These studies showed that cell motion was depressed in myocytes treated with superfusates from the pressure-overloaded hearts but was normal with the superfusates from the control hearts. Finally, hemodynamic pressure overloading in vivo under physiological conditions was also shown to result in de novo intramyocardial TNF-alpha mRNA biosynthesis. In conclusion, this study constitutes the initial demonstration that the adult mammalian myocardium elaborates biologically active TNF-alpha, both ex vivo and in vivo, in response to hemodynamic pressure overloading.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9242179     DOI: 10.1161/01.res.81.2.187

Source DB:  PubMed          Journal:  Circ Res        ISSN: 0009-7330            Impact factor:   17.367


  55 in total

Review 1.  Clinical implications of tumour necrosis factor alpha antagonism in patients with congestive heart failure.

Authors:  G Torre-Amione; S S Stetson; J A Farmer
Journal:  Ann Rheum Dis       Date:  1999-11       Impact factor: 19.103

Review 2.  The role of anti-cytokine therapy in the failing heart.

Authors:  A Deswal; A Misra; B Bozkurt
Journal:  Heart Fail Rev       Date:  2001-03       Impact factor: 4.214

Review 3.  Activation of cytokines as a mechanism of disease progression in heart failure.

Authors:  B Bozkurt
Journal:  Ann Rheum Dis       Date:  2000-11       Impact factor: 19.103

4.  TNF alpha is required for hypoxia-mediated right ventricular hypertrophy.

Authors:  R M Smith; J McCarthy; M N Sack
Journal:  Mol Cell Biochem       Date:  2001-03       Impact factor: 3.396

5.  Cardiomyopathy is linked to complement activation.

Authors:  Marina Afanasyeva; Noel R Rose
Journal:  Am J Pathol       Date:  2002-08       Impact factor: 4.307

Review 6.  Optimising outcomes in end-stage heart failure: differences in therapeutic responses between diverse ethnic groups.

Authors:  Shigetake Sasayama
Journal:  Drug Saf       Date:  2004       Impact factor: 5.606

7.  Plasma levels of tumor necrosis factor-alpha and its receptors in patients with mitral stenosis and sinus rhythm undergoing percutaneous balloon valvuloplasty.

Authors:  Kumral Ergun Cagli; Dursun Aras; Serkan Topaloglu; Bilal Geyik; Selime Ayaz; Goksel Cagirci; Halil Lutfi Kisacik; Sule Korkmaz
Journal:  Heart Vessels       Date:  2010-03-26       Impact factor: 2.037

8.  The MEKK1-JNK pathway plays a protective role in pressure overload but does not mediate cardiac hypertrophy.

Authors:  Junichi Sadoshima; Olivier Montagne; Qian Wang; Guiping Yang; Jill Warden; Jing Liu; Gen Takagi; Vijaya Karoor; Chull Hong; Gary L Johnson; Dorothy E Vatner; Stephen F Vatner
Journal:  J Clin Invest       Date:  2002-07       Impact factor: 14.808

Review 9.  Biologics and heart failure in rheumatoid arthritis: are we any wiser?

Authors:  Maria I Danila; Nivedita M Patkar; Jeffrey R Curtis; Kenneth G Saag; Gim Gee Teng
Journal:  Curr Opin Rheumatol       Date:  2008-05       Impact factor: 5.006

10.  Mao-to Prolongs the Survival of and Reduces TNF-alpha Expression in Mice with Viral Myocarditis.

Authors:  Zhu Shijie; Junji Moriya; Jun'ichi Yamakawa; Rui Chen; Takashi Takahashi; Hiroyuki Sumino; Takeshi Nakahashi; Kunimitsu Iwai; Shigeto Morimoto; Nobuo Yamaguchi; Tsugiyasu Kanda
Journal:  Evid Based Complement Alternat Med       Date:  2008-02-24       Impact factor: 2.629

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.